What drugs target Glucagon-like peptide 1 receptor?

9+ drugs target Glucagon-like peptide 1 receptor, including Victoza, Albugon, Byetta, Rybelsus, Liraglutid.

What drug classes act on Glucagon-like peptide 1 receptor?

Drug classes acting on Glucagon-like peptide 1 receptor include GLP-1 Receptor Agonist [EPC], GLP-1 Receptor Agonist, Insulin Analog [EPC].

9 drugs 9 marketed

All drugs that target Glucagon-like peptide 1 receptor — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Victoza · Novo Nordisk · GLP-1 Receptor Agonist [EPC] · Metabolic
Albugon · GSK · GLP-1 Receptor Agonist · Metabolic
Byetta · AstraZeneca · GLP-1 Receptor Agonist [EPC] · Metabolic
Byetta works by activating the glucagon-like peptide 1 receptor, which helps regulate blood sugar levels.
Rybelsus · Pfizer · Metabolic
Liraglutid · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Metabolic
Saxenda · Seoul National University Hospital · Metabolic
Byetta · AstraZeneca · GLP-1 Receptor Agonist [EPC] · Metabolic
Byetta works by mimicking the action of a natural hormone in the body to regulate blood sugar levels.
Adlyxin · Sanofi-Aventis Us Llc · Insulin Analog [EPC] · Metabolic
Adlyxin works by mimicking the action of the GLP-1 hormone to help regulate blood sugar levels.
Victoza · Hanmi Pharmaceutical Company Limited · Metabolic